{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:44:56Z","timestamp":1790959496897,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jinf.2021.07.029","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T04:51:14Z","timestamp":1627447874000},"page":"339-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection"],"prefix":"10.1016","volume":"83","author":[{"given":"Anuradha","family":"Rajamanickam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathella Pavan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekaran","family":"Padmapriyadarsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Nancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhini","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushiyasri","family":"Karunanithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Munisankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivasa","family":"BM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Mariam","family":"Renji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Ambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Venkataramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.07.029_bib0001","unstructured":"Report WT. 2020."},{"key":"10.1016\/j.jinf.2021.07.029_bib0002","unstructured":"WHO C-R. 2021 [April 5]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"issue":"2","key":"10.1016\/j.jinf.2021.07.029_bib0003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijtb.2020.02.004","article-title":"Tuberculosis and novel Wuhan coronavirus infection: pathological interrelationship","volume":"67","author":"Yasri","year":"2020","journal-title":"Indian J Tuberc"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.029_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","article-title":"Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects","volume":"27","author":"Visca","year":"2021","journal-title":"Pulmonology"},{"key":"10.1016\/j.jinf.2021.07.029_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106204","article-title":"Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy","volume":"175","author":"Torre","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2021.07.029_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.02.090","article-title":"Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2","author":"Petrone","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2021.07.029_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149125","article-title":"HIATUS consortium. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection","volume":"131","author":"Riou","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.029_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01398-2020","article-title":"Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases","volume":"56","author":"Tadolini","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2021.07.029_bib0009","first-page":"ciaa1198","article-title":"Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa","author":"Boulle","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2021.07.029_bib0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijid.2021.04.075","article-title":"S\u00e1nchez-Montalv\u00e1 A. Impact of the COVID-19 pandemic on tuberculosis management in Spain","volume":"108","author":"Aznar","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2021.07.029_bib0011","series-title":"Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis","author":"Sheerin","year":"2020"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.029_bib0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases-case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2021.07.029_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102887","article-title":"The four horsemen of a viral apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19)","volume":"58","author":"Domingo","year":"2020","journal-title":"EBioMed"},{"issue":"12","key":"10.1016\/j.jinf.2021.07.029_bib0014","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"10223","key":"10.1016\/j.jinf.2021.07.029_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"key":"10.1016\/j.jinf.2021.07.029_bib0016","doi-asserted-by":"crossref","first-page":"m1375","DOI":"10.1136\/bmj.m1375","article-title":"COVID-19: four fifths of cases are asymptomatic, China figures indicate","volume":"369","author":"Day","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jinf.2021.07.029_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.029_bib0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42003-021-01649-6","article-title":"SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus","volume":"4","author":"Dogan","year":"2021","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.029_bib0019","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1080\/22221751.2020.1835448","article-title":"Validation and clinical evaluation of a SARS-CoV-2\u2005surrogate virus neutralisation test (sVNT)","volume":"9","author":"Meyer","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"10.1016\/j.jinf.2021.07.029_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244126","article-title":"Antibody response to SARS-CoV-2 infection in humans: a systematic review","volume":"15","author":"Post","year":"2020","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.029_bib0021","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/jmv.26740","article-title":"Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses","volume":"93","author":"Sarkar","year":"2021","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.029_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003346","article-title":"Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analyze","volume":"17","author":"Buitrago-Garcia","year":"2020","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.jinf.2021.07.029_bib0023","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol"},{"key":"10.1016\/j.jinf.2021.07.029_bib0024","doi-asserted-by":"crossref","unstructured":"Yu Chen, Yaguo Wang, Joy Fleming, Yanhong Yu, Ye Gu, Chang Liu, Lichao Fan, Xiaodan Wang, Moxin Cheng, Lijun Bi, Yongyu Liu. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv 2020.03.10.20033795; doi:https:\/\/doi.org\/10.1101\/2020.03.10.20033795.","DOI":"10.1101\/2020.03.10.20033795"},{"key":"10.1016\/j.jinf.2021.07.029_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.jinf.2021.07.029_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2020.06.039","article-title":"Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus","volume":"81","author":"Skevaki","year":"2020","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2021.07.029_bib0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.medcli.2020.05.017","article-title":"Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analyze","volume":"155","author":"Soraya","year":"2020","journal-title":"Med Clin"},{"key":"10.1016\/j.jinf.2021.07.029_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102020","article-title":"Pathology of TB\/COVID-19 Co-Infection: the phantom menace","volume":"126","author":"Mousquer","year":"2021","journal-title":"Tuberculosis (Edinb)"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:31Z","timestamp":1759008811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321003728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0163445321003728"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.029","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}